Astrazeneca: Q2 Earnings Snapshot

By The Associated Press
July 27, 2026 | 2:17 AM

CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Monday reported second-quarter earnings of $2.51 billion.

The Cambridge, Britain-based company said it had net income of $1.61 per share. Earnings, adjusted for non-recurring costs, were $2.63 per share.

The pharmaceutical posted revenue of $15.38 billion in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $15.31 billion.

Astrazeneca shares have declined roughly 8% since the beginning of the year. The stock has risen 16% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at https://www.zacks.com/ap/AZN

Serena Williams and Carlos Alcaraz knocked out of mixed doubles at the U.S. Open

By The Associated Press
August 25, 2026 | 6:17 PM

NEW YORK (AP) — Serena Williams getting back on the court at the U.S. Open after a four-year absence and Carlos Alcaraz returning to competitive tennis after being out the past four months with injury brought cheers and nostalgia to the Grand Slam tournament. The celebration was short-lived. After winning their debut playing together, Williams and Alcaraz got knocked out in the mixed doubles quarterfinals by Belinda Bencic and Flavio Cobolli 5-4 (4), 4-1 on Tuesday. Cobolli before the match called their opponents “the queen of tennis and the king of now.” The star-studded duo with a combined eight U.S. Open singles championships certainly earned that praise. Williams and Alcaraz bounced back from a slow start in the first round to defeat Erin Routliffe and Lloyd Glasspool 5-3, 4-1, much to the delight of fans inside Arthur Ashe Stadium who were clearly on their side.

Related Stories